Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
AANA developed policies and procedures that align with best available evidence for treating patients taking GLP-1 receptor agonists, which increase insulin synthesis and secretion, suppress glucagon secretion, reduce food intake through appetite suppression, slow gastric emptying, and promote beta-cell proliferation
Dietary effects on incretin hormone secretion
Cani PD, Lecourt E, Dewulf EM, et al
The presence of GLP-1 receptors in the central nervous system, particularly in the ventral tegmental area (VTA) and nucleus accumbens (NAc), suggests their involvement in reward processing and motivation
Navigating Weight Loss Medications: A Short Course for Dietitians Want to build a deeper, strategic understanding
Wash your hands, disinfect the vial stopper, and use sterile single-use supplies
US$ 25.41
US$ 28.37
US$ 21.25
US$ 26.66
US$ 29.53
US$ 23.22
US$ 24.34
US$ 29.13
US$ 25.23
US$ 29.32
